相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Correlation of Vascular Endothelial Growth Factor Expression With Tumor Recurrence and Poor Prognosis in Patients With pN0 Gastric Cancer
Yan-Feng Liu et al.
WORLD JOURNAL OF SURGERY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma
Manish A. Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications
Hong-Feng Gou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Expression of Matrix Metalloproteinase-9 mRNA and Vascular Endothelial Growth Factor Protein in Gastric Carcinoma and its Relationship to its Pathological Features and Prognosis
Qiong Yang et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2010)
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers
B. F. El-Rayes et al.
ANNALS OF ONCOLOGY (2010)
Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases
Xiao-Lei Wang et al.
BMC CANCER (2010)
The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma
F. -H. Han et al.
EJSO (2010)
VEGF and Cortactin Expression Are Independent Predictors of Tumor Recurrence Following Curative Resection of Gastric Cancer
Xin Wang et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma
Jeeyun Lee et al.
APMIS (2009)
Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
S. J. Schoenleber et al.
BRITISH JOURNAL OF CANCER (2009)
Recent patterns in gastric cancer: A global overview
Paola Bertuccio et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer A Systematic Review with Meta-Analysis
Ping Zhan et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Vascular endothelial growth factor-D is correlated with hepatic metastasis from gastric cancer after radical gastrectomy
Jingyu Deng et al.
SURGERY (2009)
No Association of Vascular Endothelial Growth Factor-A (VEGF-A) and VEGF-C Expression with Survival in Patients with Gastric Cancer
Soo Jung Lee et al.
CANCER RESEARCH AND TREATMENT (2009)
Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer:: Association with hypoxia-inducible factor (HIF-1α) pathway, angiogenic factors production and poor prognosis
Yanislav Kolev et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Expression of cyclooxygenase-2 and vascular endothelial growth factor-C correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer
Ming-Xu Da et al.
ARCHIVES OF MEDICAL RESEARCH (2008)
Correlation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma
Jung-Hye Choi et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2008)
A role for VEGF as a negative regulator of pericyte function and vessel maturation
Joshua I. Greenberg et al.
NATURE (2008)
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
Christian Stockmann et al.
NATURE (2008)
Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: Results of a study assessing a panel of angiogenic markers
Oscar Vidal et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients
Eva Lieto et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma
J. Lee et al.
ANNALS OF ONCOLOGY (2007)
Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters
Hiroaki Saito et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer
Nikolaos I. Nikiteas et al.
GASTRIC CANCER (2007)
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
Manish A. Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Vascular endothelial growth factor signaling pathways: Therapeutic perspective
Marcin Kowanetz et al.
CLINICAL CANCER RESEARCH (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature
G. Des Guetz et al.
BRITISH JOURNAL OF CANCER (2006)
Vascular endothelial growth factor-D and its receptor VEGFR-3:: Two novel independent prognostic markers in gastric adenocarcinoma
S Jüttner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic significance of vascular endothelial growth factor D in gastric carcinoma
A Shida et al.
WORLD JOURNAL OF SURGERY (2005)
Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer
WD Gong et al.
CLINICAL CANCER RESEARCH (2005)
Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: A meta-analysis
PA Kyzas et al.
CLINICAL CANCER RESEARCH (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
N Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data
I Chou et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer
C Fondevila et al.
BRITISH JOURNAL OF CANCER (2004)
Constitutive and inducible expression and regulation of vascular endothelial growth factor
KP Xie et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
The vascular endothelial growth factor family and its receptors
AA Parikh et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2004)
Lymphangiogenesis and tumor metastasis
MS Pepper et al.
CELL AND TISSUE RESEARCH (2003)
Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma
H Shi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a Canadian Cancer Center
S Gill et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer
T Kaneko et al.
CANCER SCIENCE (2003)
Correlation of vascular endothelial growth factor-C expression with tumor-infiltrating dendritic cells in gastric cancer
A Takahashi et al.
ONCOLOGY (2002)
Systematic reviews in health care - Systematic reviews of evaluations of prognostic variables
DG Altman
BMJ-BRITISH MEDICAL JOURNAL (2001)
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
SA Stacker et al.
NATURE MEDICINE (2001)
分享论文
